Dr Houman takes on a question he hears often from men on Ozempic, Wegovy and Mounjaro, though the clip mainly pushes a guide you get by commenting.
Recap by typeshit. Post by @justin.houman.md on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Texas A&M Medicine says the wider use of GLP-1 drugs is changing how people talk about body image, weight stigma and self-worth.
Feller urges people on GLP-1s to work with a registered dietitian and their provider so they keep getting enough nutrients while losing weight.
Loading…